Leti is also actively involved in novel drug delivery technologies that are more efficient and reduce side effects. Innovative therapies will include physical effectors (pulsed ultrasounds, photonics and photo-acoustics) and 3D cell culture- and organ-on-a-chip- based regenerative medicine.

Next-generation wearable, implantable, lab-on-chip devices will be simpler to use and will offer energy efficiency, security and connectivity. They will be compatible with digital health platforms. Overall patient health data analytics will be conducted using digital biomarkers, avatars to assist in diagnosis and therapy and health maintenance coaching. These closed-loop approaches are central to ensuring better therapeutic efficacy.

Novel imaging techniques for diagnosis, including portable CT-scanner, new X-ray LEDs and optical imaging, will be integral to Leti’s health technology portfolio.

​

​

​

​

​

​Cell encapsulation (islets of Langerhans) for the treatment of diabetes

​​​Leti’s health patch for improved diagnosis of sleep apnea

Full system development (exemple of Avalun's LabPad™. Avalun is a Leti startup)

Browse the site

Alternative and Atomic Energies Agency

CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.